These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19141308)

  • 1. Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with Yi-gan san.
    Miyaoka T; Nagahama M; Tsuchie K; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):382-3. PubMed ID: 19141308
    [No Abstract]   [Full Text] [Related]  

  • 2. Yi-gan san for treatment of charles bonnet syndrome (visual hallucination due to vision loss): an open-label study.
    Miyaoka T; Furuya M; Kristian L; Wake R; Kawakami K; Nagahama M; Kawano K; Ieda M; Tsuchie K; Horiguchi J
    Clin Neuropharmacol; 2011; 34(1):24-7. PubMed ID: 21164340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration.
    Singh A; Sørensen TL
    Br J Ophthalmol; 2011 Feb; 95(2):291-2. PubMed ID: 20733019
    [No Abstract]   [Full Text] [Related]  

  • 4. Seeing the unseen: Charles Bonnet syndrome revisited.
    Nair AG; Nair AG; Shah BR; Gandhi RA
    Psychogeriatrics; 2015 Sep; 15(3):204-8. PubMed ID: 25515178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual hallucinations in Charles Bonnet syndrome can be seen in fluorodeoxyglucose-PET.
    Garde N; Skripuletz T; Pul R; Berding G; Weissenborn K; Trebst C
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E38-9. PubMed ID: 22231345
    [No Abstract]   [Full Text] [Related]  

  • 6. Hallucinations Experienced by Visually Impaired: Charles Bonnet Syndrome.
    Pang L
    Optom Vis Sci; 2016 Dec; 93(12):1466-1478. PubMed ID: 27529611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual hallucinations and macular degeneration: an example of the Charles Bonnet syndrome.
    Nadarajah J
    Aust N Z J Ophthalmol; 1998 Feb; 26(1):63-5. PubMed ID: 9524035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
    Lang UE; Stogowski D; Schulze D; Domula M; Schmidt E; Gallinat J; Tugtekin SM; Felber W
    J Psychopharmacol; 2007 Jul; 21(5):553-5. PubMed ID: 17446204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charles Bonnet syndrome-induced psychosis? Visual hallucinations with paranoid delusions in a visually-impaired man.
    Makarewich C; West DA
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E6. PubMed ID: 22231350
    [No Abstract]   [Full Text] [Related]  

  • 10. Is Charles Bonnet syndrome an early stage of dementia with Lewy bodies?
    Hanyu H; Takasaki A; Sato T; Akai T; Iwamoto T
    J Am Geriatr Soc; 2008 Sep; 56(9):1763-4. PubMed ID: 19166452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hallucinations in vision impairment].
    Singh A; Sørensen TL
    Ugeskr Laeger; 2011 Jan; 173(1):50. PubMed ID: 21199624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex visual hallucinations in a patient with macular degeneration: a case of the Charles Bonnet syndrome.
    Kumar B
    Age Ageing; 2013 May; 42(3):411. PubMed ID: 23443508
    [No Abstract]   [Full Text] [Related]  

  • 13. The Charles Bonnet syndrome. Visual hallucinations caused by vision impairment.
    Rovner BW
    Geriatrics; 2002 Jun; 57(6):45-6. PubMed ID: 12078038
    [No Abstract]   [Full Text] [Related]  

  • 14. Charles Bonnet syndrome in a case of cerebral venous thrombosis with fMRI-EEG correlation.
    Subasree R; Kulkarni GB; Kumar MV; Bharath RD; Sandhya M; Yadav R; Modi S; Kumar N; Panda R
    Neurol India; 2014; 62(5):557-9. PubMed ID: 25387635
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence and regression of Charles Bonnet syndrome in vascular age-related macular degeneration.
    Meyer CH; Fleckenstein M; Rodrigues EB; Mennel S
    Br J Ophthalmol; 2011 Aug; 95(8):1173-4; author reply 1174. PubMed ID: 21551463
    [No Abstract]   [Full Text] [Related]  

  • 16. Charles Bonnet syndrome. Diagnostic criteria.
    Santos-Bueso E; Porta-Etessam J
    Arch Soc Esp Oftalmol; 2016 Nov; 91(11):511-512. PubMed ID: 27542522
    [No Abstract]   [Full Text] [Related]  

  • 17. What associates Charles Bonnet syndrome with age-related macular degeneration?
    Vojniković B; Radeljak S; Dessardo S; Zarković-Palijan T; Bajek G; Linsak Z
    Coll Antropol; 2010 Apr; 34 Suppl 2():45-8. PubMed ID: 21305724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Charles Bonnet syndrome].
    Görgens K; Liedtke M
    Psychiatr Prax; 1998 Mar; 25(2):85-6. PubMed ID: 9577852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charles Bonnet syndrome--elderly people and visual hallucinations.
    Jacob A; Prasad S; Boggild M; Chandratre S
    BMJ; 2004 Jun; 328(7455):1552-4. PubMed ID: 15217875
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic options in Charles Bonnet syndrome.
    Batra A; Bartels M; Wormstall H
    Acta Psychiatr Scand; 1997 Aug; 96(2):129-33. PubMed ID: 9272197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.